Additional Proxy Soliciting Materials (definitive) (defa14a)
April 06 2017 - 04:41PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Under §240.14a-12
|
Coherus
BioSciences, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
1.
|
|
Title of each class of securities to which transaction applies:
|
|
|
2.
|
|
Aggregate number of securities to which transaction applies:
|
|
|
3.
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
4.
|
|
Proposed maximum aggregate value of transaction:
|
|
|
5.
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
1.
|
|
Amount previously paid:
|
|
|
2.
|
|
Form, Schedule or Registration Statement No.:
|
|
|
3.
|
|
Filing party:
|
|
|
4.
|
|
Date Filed:
|
*** Exercise Your
Right
to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on May 17, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meeting Information
|
|
|
|
|
COHERUS BIOSCIENCES INC
|
|
|
|
Meeting Type:
Annual Meeting
|
|
|
|
|
|
|
|
|
For holders as of:
March 24, 2017
|
|
|
|
|
|
|
|
|
Date:
May 17,
2017
Time:
2:00 PM PDT
|
|
|
|
|
|
|
|
|
Location:
|
|
Latham & Watkins LLP
|
|
|
|
|
|
|
|
|
|
|
140 Scott Drive
|
|
|
|
|
|
|
|
|
|
|
Menlo Park, CA 94025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE
SUITE 600
REDWOOD CITY, CA 94065
|
|
|
|
You are receiving this communication because you hold shares
in the above named company.
|
|
|
|
|
|
|
|
This is not a ballot. You cannot use this notice to vote
these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper copy (see
reverse side).
|
|
|
|
|
|
|
|
We encourage you to access and review all of the important
information contained in the proxy materials before voting.
|
|
|
|
|
|
|
|
See the reverse side of this notice to obtain proxy materials and voting instructions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before You Vote
How to Access the Proxy Materials
|
|
|
|
|
|
|
Proxy Materials
Available to VIEW or RECEIVE:
|
|
|
|
|
|
|
|
|
|
|
1. Annual Report 2. Notice & Proxy Statement
|
|
|
|
|
|
|
How to View Online:
|
|
|
|
|
|
|
|
|
|
|
Have the information that is printed in the box marked by the arrow
(located on the following page) and visit:
www.proxyvote.com.
|
|
|
|
|
|
|
How to Request and Receive a PAPER or E-MAIL
Copy:
|
|
|
|
|
|
|
|
|
|
|
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
|
|
|
|
|
|
|
|
|
|
|
|
1)
BY INTERNET
:
|
|
www.proxyvote.com
|
|
|
|
|
|
|
2)
BY TELEPHONE
:
|
|
1-800-579-1639
|
|
|
|
|
|
|
3)
BY E-MAIL*
:
|
|
sendmaterial@proxyvote.com
|
|
|
|
|
|
|
* If
requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow
(located on the following page) in the subject line.
|
|
|
|
|
|
|
Requests,
instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 03, 2017 to facilitate timely delivery.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How To Vote
Please Choose One of the Following Voting Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vote In Person:
Many shareholder meetings have attendance requirements
including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot
to vote these shares.
Vote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow
available and follow the instructions.
Vote By
Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote
FOR the following:
|
|
|
1.
|
|
Election of Directors
|
|
|
|
|
Nominees
|
|
|
01
|
|
Dennis M. Lanfear 02 Mats
Wahlstrom 03 James I. Healy, MD, PhD
|
The Board of Directors recommends you vote FOR proposals 2. and 3.
|
2.
|
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017.
|
|
3.
|
A non-binding advisory resolution to approve our executive compensation (a Say on Pay vote).
|
NOTE:
Such other business as may properly come before the meeting or any adjournment thereof.
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Mar 2023 to Mar 2024